Hopital Robert Debre; DERMATOLOGIE

Reims 51092

0 studies enrolling now · 2 studies all time

What they study most

Advanced BRAFV600 Wild-type Melanoma, Malignant Melanoma

Studies at this site

• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early
• A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma — Completed